FilingReader Intelligence
Fosun Pharma announces progress in A-share and H-share repurchases
April 2, 2025 at 05:13 PM UTC•By FilingReader AI
Shanghai Fosun Pharmaceutical Group (SSE:600196) announced progress in its A-share and H-share repurchase programs. As of March 31, 2025, the company had repurchased 1,613,300 A-shares, representing approximately 0.0604% of the total share capital, for a total of CNY 3,999.41 million. The A-share repurchase prices ranged from CNY 24.54 to CNY 25.39 per share.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
SSE:600196•Shanghai Stock Exchange
PharmaceuticalsShanghai Blue Chip
News Alerts
Get instant email alerts when Shanghai Fosun Pharmaceutical Group publishes news
Free account required • Unsubscribe anytime